Trupanion (TRUP) Expected to Announce Quarterly Sales of $69.05 Million

Wall Street brokerages forecast that Trupanion (NASDAQ:TRUP) will report $69.05 million in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Trupanion’s earnings, with the lowest sales estimate coming in at $68.70 million and the highest estimate coming in at $69.40 million. Trupanion reported sales of $54.73 million in the same quarter last year, which indicates a positive year-over-year growth rate of 26.2%. The business is expected to issue its next earnings report after the market closes on Tuesday, May 1st.

According to Zacks, analysts expect that Trupanion will report full year sales of $296.40 million for the current fiscal year, with estimates ranging from $294.30 million to $298.50 million. For the next year, analysts forecast that the firm will post sales of $351.60 million per share, with estimates ranging from $343.00 million to $360.20 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that cover Trupanion.

How to Become a New Pot Stock Millionaire

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Tuesday, February 13th. The financial services provider reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.03). Trupanion had a negative return on equity of 6.66% and a negative net margin of 0.62%. The firm had revenue of $66.55 million during the quarter, compared to analysts’ expectations of $65.60 million.

Several equities research analysts recently weighed in on TRUP shares. Lake Street Capital lifted their price objective on Trupanion from $32.00 to $41.00 and gave the stock a “buy” rating in a report on Wednesday, February 14th. ValuEngine lowered Trupanion from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. BidaskClub lowered Trupanion from a “hold” rating to a “sell” rating in a report on Tuesday, March 27th. Cowen reissued an “outperform” rating and issued a $38.00 price objective (up previously from $32.00) on shares of Trupanion in a report on Wednesday, February 14th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $34.00 price objective (up previously from $33.00) on shares of Trupanion in a report on Wednesday, February 14th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $35.57.

TRUP traded down $1.19 during trading hours on Tuesday, hitting $27.74. The stock had a trading volume of 332,356 shares, compared to its average volume of 384,024. Trupanion has a 1 year low of $14.87 and a 1 year high of $37.13. The firm has a market cap of $835.75, a P/E ratio of -396.29 and a beta of 0.57. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.89 and a current ratio of 1.89.

In other Trupanion news, Director Murray B. Low sold 3,000 shares of Trupanion stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $28.42, for a total transaction of $85,260.00. Following the completion of the transaction, the director now owns 194,281 shares of the company’s stock, valued at approximately $5,521,466.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Darryl Rawlings sold 3,500 shares of Trupanion stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $34.36, for a total value of $120,260.00. Following the transaction, the insider now directly owns 1,382,976 shares of the company’s stock, valued at approximately $47,519,055.36. The disclosure for this sale can be found here. Insiders have sold a total of 21,500 shares of company stock valued at $642,465 in the last ninety days. Insiders own 31.24% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. Wells Fargo & Company MN grew its holdings in Trupanion by 173.7% during the 3rd quarter. Wells Fargo & Company MN now owns 30,819 shares of the financial services provider’s stock valued at $813,000 after buying an additional 19,558 shares in the last quarter. Hamilton Lane Advisors LLC boosted its position in shares of Trupanion by 92.5% during the 4th quarter. Hamilton Lane Advisors LLC now owns 120,611 shares of the financial services provider’s stock valued at $3,530,000 after acquiring an additional 57,971 shares during the last quarter. King Luther Capital Management Corp boosted its position in shares of Trupanion by 11.6% during the 4th quarter. King Luther Capital Management Corp now owns 64,405 shares of the financial services provider’s stock valued at $1,885,000 after acquiring an additional 6,710 shares during the last quarter. California Public Employees Retirement System boosted its position in shares of Trupanion by 7.8% during the 3rd quarter. California Public Employees Retirement System now owns 45,509 shares of the financial services provider’s stock valued at $1,202,000 after acquiring an additional 3,309 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its position in shares of Trupanion by 113.0% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 79,456 shares of the financial services provider’s stock valued at $2,099,000 after acquiring an additional 42,156 shares during the last quarter. 74.81% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/04/23/trupanion-trup-expected-to-announce-quarterly-sales-of-69-05-million.html.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply